Target Name: SYT8
NCBI ID: G90019
Review Report on SYT8 Target / Biomarker Content of Review Report on SYT8 Target / Biomarker
SYT8
Other Name(s): Synaptotagmin-8 isoform 1 | synaptotagmin 8 | Synaptotagmin-8 | Synaptotagmin 8, transcript variant 1 | synaptotagmin VIII | Synaptotagmin-8 (isoform 3) | Synaptotagmin 8, transcript variant 4 | SYT8 variant 1 | SytVIII | SYT8 variant 4 | Synaptotagmin-8 isoform 4 | SYT8_HUMAN | Synaptotagmin VIII | SYT8 variant 3 | sytVIII | Synaptotagmin 8 | Synaptotagmin 8, transcript variant 3

SYN8: A Potential Drug Target for Neurological Disorders

Synaptotagmin-8 (SYN8) is a protein that is expressed in the nervous system and has been identified as a potential drug target in the treatment of various neurological disorders. The protein is a member of the neurotransmitter receptors family and is involved in the transmission of synaptic signals between neurons.

SYN8 is a 14-kDa protein that is expressed in the rat central nervous system (CNS) and has been shown to play a role in the transmission of synaptic signals between neurons. The protein is a member of the neurotransmitter receptors family and is involved in the regulation of neuronal communication.

SYN8 has been shown to be involved in the transmission of synaptic signals between neurons in the CNS, including the regulation of neurotransmitter release and the modulation of neuronal excitability. The protein has also been shown to play a role in the regulation of sleep-wake cycles and has been linked to the development of certain neurological disorders.

SYN8 has also been shown to be involved in the regulation of pain perception and the modulation of pain modalities. The protein has been shown to play a role in the regulation of neurotransmitter release in response to pain stimuli and has been linked to the development of chronic pain disorders.

In addition to its role in the regulation of synaptic signals, SYN8 has also been shown to play a role in the regulation of cellular processes in the CNS, including the regulation of neurogenesis and the modulation of neuroplasticity. The protein has also been shown to play a role in the regulation of immune response and has been linked to the development of certain neurological disorders.

Given its involvement in the regulation of synaptic signals and its potential role in the treatment of neurological disorders, SYN8 has emerged as a promising drug target for the development of new treatments for a variety of neurological disorders. Further research is needed to fully understand the role of SYN8 in the nervous system and to develop effective treatments for the treatment of synaptic disorders.

Protein Name: Synaptotagmin 8

Functions: Isoform 4 may play a role in the trafficking and exocytosis of secretory vesicles in non-neuronal tissues. Mediates Ca(2+)-regulation of exocytosis acrosomal reaction in sperm. May mediate Ca(2+)-regulation of exocytosis in insulin secreted cells (By similarity)

The "SYT8 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SYT8 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

SYT9 | SYTL1 | SYTL2 | SYTL3 | SYTL4 | SYTL5 | SYVN1 | SZRD1 | SZRD1P1 | SZT2 | T-Box transcription factor (TBX) | T-Type Calcium Channel | TAAR1 | TAAR2 | TAAR3P | TAAR5 | TAAR6 | TAAR8 | TAAR9 | TAB1 | TAB2 | TAB2-AS1 | TAB3 | TAC1 | TAC3 | TAC4 | TACC1 | TACC2 | TACC3 | Tachykinin Receptor | TACO1 | TACR1 | TACR2 | TACR3 | TACSTD2 | TADA1 | TADA2A | TADA2B | TADA3 | TAF1 | TAF10 | TAF11 | TAF11L2 | TAF11L3 | TAF12 | TAF12-DT | TAF13 | TAF15 | TAF1A | TAF1A-AS1 | TAF1B | TAF1C | TAF1D | TAF1L | TAF2 | TAF3 | TAF4 | TAF4B | TAF5 | TAF5L | TAF5LP1 | TAF6 | TAF6L | TAF7 | TAF7L | TAF8 | TAF9 | TAF9B | TAFA1 | TAFA2 | TAFA3 | TAFA4 | TAFA5 | TAFAZZIN | TAGAP | TAGAP-AS1 | TAGLN | TAGLN2 | TAGLN3 | TAK1 | TAL1 | TAL2 | TALDO1 | TAM Receptor tyrosine kinase | TAMALIN | TAMM41 | TANC1 | TANC2 | TANGO2 | TANGO6 | TANK | Tankyrase | TAOK1 | TAOK2 | TAOK3 | TAP1 | TAP2 | TAPBP | TAPBPL | TAPT1